Diabetes as a coronary artery disease risk equivalent: before a change of paradigm?

被引:24
作者
Saely, Christoph H. [2 ]
Aczel, Stefan [2 ]
Koch, Lorena
Schmid, Fabian
Marte, Thomas [2 ]
Huber, Kurt [3 ]
Drexel, Heinz [1 ,2 ,4 ,5 ]
机构
[1] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, VIVIT, A-6807 Feldkirch, Austria
[2] Acad Teaching Hosp Feldkirch, Dept Med, A-6807 Feldkirch, Austria
[3] Wilhelminenhosp, Dept Med Cardiol & Emergency Med 3, Vienna, Austria
[4] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[5] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2010年 / 17卷 / 01期
关键词
cardiovascular risk; coronary angiography; coronary artery disease; type; 2; diabetes; LONG-TERM SURVIVAL; 10-YEAR FOLLOW-UP; HEART-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; PRIMARY PREVENTION; MORTALITY; IMPACT; MELLITUS; COMPLICATIONS;
D O I
10.1097/HJR.0b013e32833100f0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Current guidelines consider diabetes per se as a coronary artery disease (CAD) risk equivalent. We aimed at investigating the contribution of baseline coronary atherosclerosis to the risk of diabetic patients for future vascular events. Design Prospective cohort study. Methods Vascular events were recorded over 4 years in 750 consecutive patients undergoing coronary angiography for the evaluation of stable CAD. Results From our patients, 244 had neither type 2 diabetes (T2DM) nor significant CAD (i.e. coronary stenoses >= 50%) at the baseline angiography, 50 had T2DM but not significant CAD, 342 did not have T2DM but had significant CAD, and 114 had both T2DM and significant CAD. Nondiabetic patients without significant CAD had an event rate of 9.0%. The event rate was similar in T2DM patients without significant CAD (8.0%, P=0.951), but higher in nondiabetic patients with significant CAD (24.9%, P<0.001). Patients with T2DM and significant CAD had the highest event rate (43.0%). Importantly, T2DM patients without significant CAD had a significantly lower event rate than nondiabetic patients with significant CAD (P=0.008). Conclusion T2DM per se is not a CAD risk equivalent. Moderate-risk diabetic patients without significant CAD and very high-risk diabetic patients with significant CAD add up to a grand total of high-risk diabetic patients, this is why diabetes seems to be a CAD risk equivalent in many epidemiological studies. Eur J Cardiovasc Prev Rehabil 17:94-99 (C) 2010 The European Society of Cardiology
引用
收藏
页码:94 / 99
页数:6
相关论文
共 27 条
  • [1] Evidence-based medication and revascularization:: powerful tools in the management of patients with diabetes and coronary artery disease:: a report from the Euro Heart Survey on diabetes and the heart
    Anselmino, Matteo
    Malmberg, Klas
    Ohrivik, John
    Ryden, Lars
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2008, 15 (02): : 216 - 223
  • [2] Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease - 10-year follow-up of the Hoorn Study
    Becker, A
    Bos, G
    de Vegt, F
    Kostense, PJ
    Dekker, JM
    Nijpels, G
    Heine, RJ
    Bouter, LM
    Stehouwer, CDA
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (15) : 1406 - 1413
  • [3] Is diabetes a coronary risk equivalent? Systematic review and meta-analysis
    Bulugahapitiya, U.
    Siyambalapitiya, S.
    Sithole, J.
    Idris, I.
    [J]. DIABETIC MEDICINE, 2009, 26 (02) : 142 - 148
  • [4] Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association
    Buse, John B.
    Ginsberg, Henry N.
    Bakris, George L.
    Clark, Nathaniel G.
    Costa, Fernando
    Eckel, Robert
    Fonseca, Vivian
    Gerstein, Hertzel C.
    Grundy, Scott
    Nesto, Richard W.
    Pignone, Michael P.
    Plutzky, Jorge
    Porte, Daniel
    Redberg, Rita
    Stitzel, Kimberly F.
    Stone, Neil J.
    [J]. CIRCULATION, 2007, 115 (01) : 114 - 126
  • [5] Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study
    Buyken, Anette E.
    von Eckardstein, Arnold
    Schulte, Helmut
    Cullen, Paul
    Assmann, Gerd
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 (02): : 230 - 236
  • [6] The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men
    Cho, E
    Rimm, EB
    Stampfer, MJ
    Willett, WC
    Hu, FB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) : 954 - 960
  • [7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [8] Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?
    Drexel, H
    Aczel, S
    Marte, T
    Benzer, W
    Langer, P
    Moll, W
    Saely, CH
    [J]. DIABETES CARE, 2005, 28 (01) : 101 - 107
  • [9] PLASMA TRIGLYCERIDES AND 3 LIPOPROTEIN CHOLESTEROL FRACTIONS ARE INDEPENDENT PREDICTORS OF THE EXTENT OF CORONARY ATHEROSCLEROSIS
    DREXEL, H
    AMANN, FW
    BERAN, J
    RENTSCH, K
    CANDINAS, R
    MUNTWYLER, J
    LUETHY, A
    GASSER, T
    FOLLATH, F
    [J]. CIRCULATION, 1994, 90 (05) : 2230 - 2235
  • [10] Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
    Evans, JMM
    Wang, JX
    Morris, D
    [J]. BRITISH MEDICAL JOURNAL, 2002, 324 (7343): : 939 - 942A